William Conkling Cyclo Therapeutics, Inc. (CYTH) insider trading activity

William Conkling is Director of Cyclo Therapeutics, Inc.. Currently has a direct ownership of 50,230 shares of CYTH, which is worth approximately $45,709. The most recent transaction as insider was on Nov 15, 2024, when has been sold 16,660 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.2K

0% 3M change

209.2% 12M change

Total Value Held $45,709

WILLIAM CONKLING Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2024	BUY Grant, award, or other acquisition	-	16,660 Added 24.91%	50,230 Common Stock
Aug 16 2024	BUY Grant, award, or other acquisition	-	8,731 Added 20.64%	33,570 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	-	8,594 Added 25.71%	24,839 Common Stock
Feb 13 2024	BUY Grant, award, or other acquisition	-	6,330 Added 28.04%	16,245 Common Stock
Nov 28 2023	BUY Grant, award, or other acquisition	-	7,466 Added 42.95%	9,915 Common Stock
Aug 18 2023	BUY Grant, award, or other acquisition	-	2,449 Added 50.0%	2,449 Common Stock

Also insider at

RFL

Rafael Holdings, Inc. Real Estate

Chief Executive Officer